Evidence map›Paper›PMID 27433800›Full record

ArticlePloS one2016

Analysis of the Molecular Evolution of Hepatitis B Virus Genotypes in Symptomatic Acute Infections in Argentina.

María Belén Rodrigo, Laura Noelia Mojsiejczuk, Carolina Torres, Ina Sevic, María Mora González López Ledesma, Paula Soledad Perez, María Belén Bouzas, Omar Galdame, Sebastián Marciano, Hugo Fainboim and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

María Belén RodrigoCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
Laura Noelia MojsiejczukCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
Carolina TorresCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
Ina SevicCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
María Mora González López LedesmaCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
Paula Soledad PerezCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
María Belén BouzasUnidad de Virología, Hospital de Enfermedades Infecciosas ''F. Muñiz", Ciudad Autónoma de Buenos Aires, Argentina.
Omar GaldameUnidad de Hepatología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Sebastián MarcianoUnidad de Hepatología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Hugo FainboimUnidad de Hepatopatías Infecciosas, Hospital de Enfermedades Infecciosas ''F. Muñiz", Ciudad Autónoma de Buenos Aires, Argentina.
Diego Martín FlichmanCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
Rodolfo Héctor CamposCátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina.
University of Buenos Aires · ARHospital Italiano de Buenos Aires · ARHospital Muñiz · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) is a globally distributed human pathogen that leads to both self-limited and chronic infections. At least eight genotypes (A-H) with distinct geographical allocations and phylodynamic behaviors have been described. They differ substantially in many virological and probably some clinical parameters. The aim of this study was to analyze full-length HBV genome sequences from individuals with symptomatic acute HBV infections using phylogenetic and coalescent methods. The phylogenetic analysis resulted in the following subgenotype distribution: F1b (52.7%), A2 (18.2%), F4 (18.2%) and A1, B2, D3 and F2a 1.8% each. These results contrast with those previously reported from chronic infections, where subgenotypes F1b, F4, A2 and genotype D were evenly distributed. This differential distribution might be related to recent internal migrations and/or intrinsic biological features of each viral genotype that could impact on the probability of transmission. The coalescence analysis showed that after a diversification process started in the 80s, the current sequences of subgenotype F1b were grouped in at least four highly supported lineages, whereas subgenotype F4 revealed a more limited diversification pattern with most lineages without offspring in the present. In addition, the genetic characterization of the studied sequences showed that only two of them presented mutations of clinical relevance at S codifyng region and none at the polymerase catalytic domains. Finally, since the acute infections could be an expression of the genotypes currently being transmitted to new hosts, the predominance of subgenotype F1b might have epidemiological, as well as, clinical relevance due to its potential adverse disease outcome among the chronic cases.

Indexed as

Evolution, MolecularDNA, ViralGenotypeHepatitis BHepatitis B Surface AntigensHepatitis B virusHumansPhylogenySequence Analysis, DNADNA, ViralHepatitis B Surface Antigens

Identifiers

PMID27433800
PMCPMC4951016
OpenAlexW2505984166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.